Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Redox Reactions01:24

Redox Reactions

55.7K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
55.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective.

Biochimica et biophysica acta. Molecular basis of disease·2024
Same author

Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity.

Cardiovascular toxicology·2024
Same author

Targeting mitochondria with small molecules: A promising strategy for combating Parkinson's disease.

Mitochondrion·2024
Same author

Redox modulating small molecules having antimalarial efficacy.

Biochemical pharmacology·2023
Same author

Correction: Impact of intravascular hemolysis in malaria on liver dysfunction: Involvement of hepatic free heme overload, NF-κB activation, and neutrophil infiltration.

The Journal of biological chemistry·2019
Same author

Withdrawal: Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal.

The Journal of biological chemistry·2019

相关实验视频

Updated: Jul 12, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.6K

具有抗癌活性的小分子还氧化调节剂:全面的机制更新

Chinmay Pal1

  • 1Department of Chemistry, Gobardanga Hindu College, North 24 Parganas, West Bengal, 743273, India.

Free radical biology & medicine
|October 28, 2023
PubMed
概括

抗癌药物正在开发中,以准细胞的氧化还原平衡. 这些疗法旨在通过操纵氧化减氧过程来破坏癌细胞的生长和生存,为癌症治疗提供了新的希望.

科学领域:

  • 在瘤学瘤学.
  • 生物化学 生化学
  • 分子生物学分子生物学

背景情况:

  • 氧化还原调节,即氧化减氧的平衡,在细胞功能中至关重要.
  • 异常的氧化还原动力学与癌症的发展和治疗耐药性有关.
  • 向氧化还原通路为新型抗癌疗法提供了一个有前途的战略.

研究的目的:

  • 综合审查抗癌分子针对氧化还原通路的机制.
  • 探索氧化还原信号在癌症进展和抵抗中的作用.
  • 讨论基于氧化还原的癌症治疗的挑战和未来方向.

主要方法:

  • 对抗癌症药物及其氧化还原调节机制的文献综述.
  • 对瘤发生中的氧化还原信号研究的分析.
  • 检查诱导癌细胞中氧化应激和亡的策略.

主要成果:

  • 抗癌分子通过扰乱氧化还原平衡来破坏癌细胞的增殖和生存.
  • 反氧化向药物可以诱导氧化应激,并引发恶性细胞的亡.
  • 了解氧化还原动力学是开发有效癌症治疗的关键.

结论:

关键词:
细胞灭亡 (apoptosis) 是一种死亡的过程.癌症 癌症 癌症 癌症氧化应激是一种氧化应激.有反应性氧物种的反应性氧物种.小分子分子的小分子.

更多相关视频

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

509
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

相关实验视频

Last Updated: Jul 12, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.6K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

509
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
  • 氧化还原调节是抗癌疗法的关键机制.
  • 多种抗癌化合物利用氧化还原通路对抗癌症.
  • 对新型氧化还原向剂的进一步研究有望彻底改变癌症治疗并改善患者的治疗结果.